FDA Inspection 1283114 - Solaris Pharma Corp - September 18, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Solaris Pharma Corp

Record Details

This FDA Inspection record concerns Solaris Pharma Corp, with an inspection on September 18, 2025, issued by the New Jersey District Office, covering human drugs.

Company: Solaris Pharma Corp
Inspection Date: September 18, 2025
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · 21c2d32d-4377-4be5-8382-b321a855a9ae

Violation Codes1

21 CFR 314.80(c)(2)

Full citation text and observation details available on the Dashboard.